Clinical Decision Support Systems Market

Clinical Decision Support Systems Market Size by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) & Region - Global Forecast to 2028

Report Code: HIT 2237 Sep, 2023, by marketsandmarkets.com

The global size of clinical decision support systems market in terms of revenue was estimated to be worth USD 1.7 billion in 2023 and is poised to reach USD 2.5 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

According to The Office of the National Coordinator for Health Information Technology (ONC), as of 2021, in the US approximately 96 percent of non-federal acute care hospitals and nearly 4 in 5 office-based physicians (78%) have implemented a certified Electronic Health Record (EHR) systems. This marks significant 10-year progress since 2011 when 28% of hospitals and 34% of physicians had adopted an EHR.Additionally factors  such as rising adoption of CDSS-enabled EHRs and increasing collaborations and partnerships between stakeholders and several market players. However, requirement of high investments for the implementation of CDSS infrastructure and shortage of skilled IT professionals in the healthcare industry are expected to challenge market growth to a certain extent.

Global Clinical Decision Support Systems Market Trends

Clinical Decision Support Systems  Market

To know about the assumptions considered for the study, Request for Free Sample Report

Clinical Decision Support Systems Market Dynamics

Clinical Decision Support Systems  Market

Driver: Implementation of government regulations & initiatives to promote the adoption of HCIT solutions

In December 2021, CMS declared the publication of a Federal Register Notice to formalize its result to exercise enforcement discretion not to take action against certain payer-to-payer data exchange provisions of the May 2020 Interoperability and Patient Access final rule.In 2020, in Europe, EU Health Ministers signed a statement to collaborate and set up an eHealth common area that will permit for the free movement of electronic health records (EHR) across Europe. The statement also calls for eHealth to be an integral part of the Europe 2020 strategy. To push digital health forward, the UK government has pledged USD 347 million to enhance research and development (R&D) and produce novel therapies, devices, and diagnostics. The French government has proposed an investment plan (2022) of ~ USD 686 million, divided into five axes, to accelerate the national digital health strategy as part of the Health Innovation 2030 plan.Such initiatives/regulations are projected to further drive the demand and adoption of EHR, which will influence the adoption of clinical decision support systems (CDSS)  in major markets worldwide.

Restraint: Data security concerns related to cloud-based CDSS

A major concern with cloud-based CDSS is that data that is hosted by the vendor is not as safe as its on-premise counterpart. Information related to patient is considered very restricted and a high  privacy requirements to be maintained so that this data is available to authorized users only. Patient data through various countries is always under the scanner of legal frameworks, such as the data privacy requirements legislated through HIPAA (Health Insurance Portability and Accountability Act). Similarly, the European Union has the EU Data Protection Regulation in place with implications for guarding sensitive health data.

Opportunity: The growth potential of emerging markets

Several factors, such as the implementation of government initiatives supporting the adoption of HCIT solutions, rising government healthcare expenditure, and the presence of skilled IT experts in emerging markets, are expected to support the market growth for CDSS. Emerging markets across the Asia Pacific, such as India and China, are expected to provide significant growth potential for CDSS companies and stakeholders. Technological advancements are playing a key role as authorities in China are focusing on reforming the country’s healthcare management sector, which is currently facing challenges such as chaotic patient data, underfunded rural health centers, overburdened city hospitals, and a nationwide shortage of doctors.

Challenge: Requirement of high investments for the implementation of CDSS infrastructure

Most healthcare providers have inadequate infrastructure (technology, data, and other resources) to deploy complex healthcare IT solutions. Therefore, to implement CDSS successfully, providers must make further investments in infrastructural development to support IT systems. Investments are required to increase data storage and process capabilities for IT infrastructure. Moreover, the maintenance and software update of these systems may sometimes cost more than the price of the software. Support and maintenance services, which include software upgrades according to changing user requirements, represent a recurring expenditure that may amount to almost 30% of the total cost of ownership.

Clinical Decision Support Systems Market Ecosystem Map

Clinical Decision Support Systems  Market Ecosystem

By application, conventional CDSS segment accounted for the largest share of the global clinical decision support systems industry during forecast period

Based on application, the clinical decision support systems market is bifurcated into conventional CDSS and advanced CDSS. In 2022, the conventional CDSS segment accounted for the largest share of the market. The largest share of this segment is attributed due to widely adoption of conventional decision support systems by clinicians at the point-of-care to enhance decision-making and reduce medication errors.

By product, Integrated CDSS segment accounted for the largest share of the global Clinical decision support systems industry in 2022

Based on product, the clinical decision support systems market is bifurcated into integrated CDSS and standalone CDSS. In 2022, the integrated CDSS segment accounted for the largest share of this market. Factors such as growing pressure to cut healthcare costs, the rising geriatric population, and the increasing incidence of chronic disorders are driving the demand for these solutions. Also,healthcare providers widely use integrated CDSS to enhance the quality of care and health outcomes and decrease medication errors.

North America to witness significant growth in the clinical decision support systems industry from 2023 to 2028

Based on region, the clinical decision support systems market is segmented into-North America, Europe, Asia Pacific, and Rest of the World.In 2023, North America projected to lead market share of the market. This can be attributed to the region benefits from the presence of key players, rising significant investments in HCIT solutions, and the growing number of medication errors in the US and Canada.

Clinical Decision Support Systems  Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the prominent players operating in the clinical decision support systems market are Wolters Kluwer N.V. (Netherlands), Oracle (US), Merative (US), Change Healthcare (US), Veradigm Inc. (US), athenahealth (US), Epic Systems Corporation (US), Elsevier B.V. (Netherlands), Zynx Health (US), Koninklijke Philips N.V. (Netherlands), Medical Information Technology, Inc. (US), NextGen Healthcare, Inc. (US), CureMD Healthcare (US), Siemens Healthineers (Germany), EBSCO Information Services (US), GE HealthCare (US), eClinicalWorks (US), The Medical Algorithms Company (UK), RAMPmedical (Germany), Hera-MI (France), CareCloud, Inc. (US), VisualDx (US), Premier, Inc. (US), First Databank, Inc. (US), and Strata Decision Technology (US).

Scope of the Clinical Decision Support Systems Industry:

Report Metric

Details

Market Revenue in 2023

$1.7 billion

Estimated Value by 2028

$2.5 billion

Revenue Rate

Poised to grow at a CAGR of 7.5%

Market Driver

Implementation of government regulations & initiatives to promote the adoption of HCIT solutions

Market Opportunity

The growth potential of emerging markets

The study categorizes the clinical decision support systems market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Integrated CDSS
  • Standalone CDSS

By Delivery Mode

  • On Premise Mode
  • Cloud based Mode

By Model

  • Knowledge based CDSS
  • Non-Knowledge based CDSS

By Type

  • Therapeutic CDSS
  • Diagnostic CDSS

By Component

  • Services
  • Software
  • Hardware

By Application

  • Advanced CDSS
  • Conventional CDSS

By Level of Interactivity Level

  • Active CDSS
  • Passive CDSS

By Setting

  • In Patient
  • Ambulatory care settings

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • RoW
    • Latin America
    • Middle East and Africa

Recent Developments of Clinical Decision Support Systems Industry

  • In April 2023, Microsoft (US) and Epic Systems Corporation (US) expanded their long-standing strategic collaboration to develop and integrate generative AI into healthcare by combining the scale and power of Azure OpenAI Service with Epic’s industry-leading electronic health record (EHR) software. This co-innovation is focused on delivering a comprehensive array of generative AI- powered solutions integrated with Epic’s EHR to increase productivity, enhance patient care, and improve financial integrity of health systems globally.
  • In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR). These new features have been strategically designed to offer physicians in the United States and international markets convenient access to reliable and extensive medical content directly at the point of care, speeding up diagnosis and treatment for their patients.
  • In February 2023, The province of Nova Scotia, in collaboration with Nova Scotia Health Authority (NSHA) and IWK Health (IWK) entered into a new 10-year agreement has been signed with Oracle (US) to implement an integrated electronic care record across the province for the more than one million Nova Scotians. This technology can help improve the way health professionals use and share patient information.
  • In December 2022, athenahealth (US) announced that it had released enhancements to its athenaOne EHR to facilitate immediate administration of COVID-19 vaccines. The rollout includes communications, scheduling, workflow, documentation, and reporting capabilities.
  • In April 2022, Change Healthcare (US) launched a new edition of InterQual 2022, the firm’s flagship clinical decision support solution for delivering the latest evidence-based appropriate care.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 35)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 CDSS MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 MAJOR STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 40)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 5 HYPOTHESIS BUILDING
    2.3 MARKET SIZE ESTIMATION METHODOLOGY 
           2.3.1 APPROACH 1: REVENUE SHARE ANALYSIS
                    FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.3.2 APPROACH 2: DEMAND-SIDE ANALYSIS
                    FIGURE 7 APPROACH 2: DEMAND SIDE ANALYSIS
           2.3.3 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
                    FIGURE 8 APPROACH 3: BOTTOM-UP AND SEGMENTAL EXTRAPOLATION
                    FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
                    FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET: CAGR PROJECTION ANALYSIS
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT ANALYSIS
    2.7 LIMITATIONS 
           2.7.1 SCOPE-RELATED LIMITATIONS
           2.7.2 METHODOLOGY-RELATED LIMITATIONS
    2.8 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 56)
    FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2023 VS. 2028 (USD MILLION)
    FIGURE 19 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2023 VS. 2028 (USD MILLION)
    FIGURE 20 GEOGRAPHICAL SNAPSHOT OF CLINICAL DECISION SUPPORT SYSTEMS MARKET
 
4 PREMIUM INSIGHTS (Page No. - 63)
    4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW 
          FIGURE 21 INCREASING GOVERNMENT REGULATIONS FOR IMPLEMENTATION OF HCIT SOLUTIONS TO DRIVE MARKET
    4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT AND COUNTRY 
          FIGURE 22 INTEGRATED CDSS SEGMENT DOMINATED US MARKET IN 2022
    4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 CLINICAL DECISION SUPPORT SYSTEM MARKET: REGIONAL MIX 
          FIGURE 24 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.5 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 66)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing government regulations for implementation of HCIT solutions
                    5.2.1.2 Growing adoption of CDSS-enabled EHRs
                    5.2.1.3 Rising incidence of medication errors
           5.2.2 RESTRAINTS
                    5.2.2.1 Data security concerns in cloud-based CDSS
                    5.2.2.2 Inadequate interoperability for patient management solutions
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Development of big data and mHealth tools
                    5.2.3.2 High growth potential of emerging economies
                    5.2.3.3 Rising technological advancements
           5.2.4 CHALLENGES
                    5.2.4.1 High capital investments for CDSS infrastructure
                    5.2.4.2 Shortage of skilled IT professionals
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 27 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR CLINICAL DECISION SUPPORT SYSTEM MARKET
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE CHAIN ANALYSIS
    5.5 CASE STUDY ANALYSIS 
           5.5.1 IMPROVING PATIENT OUTCOMES
                    TABLE 2 CASE 1: RISING FOCUS ON IMPROVING PATIENT SAFETY
           5.5.2 KNOWLEDGE ANALYZER DELIVERS ADVANCED CLINICAL EXPERIENCE
                    TABLE 3 CASE 2: RISING NEED TO STREAMLINE PATIENT OUTCOMES
           5.5.3 ENHANCING PHYSICIAN EFFICIENCY
                    TABLE 4 CASE 3: RISING NEED TO IMPROVE RESPONSE TIME AND PHYSICIAN EFFICIENCY IN HEALTHCARE FACILITIES
           5.5.4 INCREASING EFFICIENCY AND HEALTHCARE OUTCOMES WITH AI
                    TABLE 5 CASE 4: RISING FOCUS ON ENHANCING EFFICIENCY AND VALUE-BASED CARE WITH AI-POWERED CDSS
    5.6 ECOSYSTEM ANALYSIS 
          FIGURE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECOSYSTEM ANALYSIS
    5.7 TECHNOLOGY ANALYSIS 
          TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
    5.8 TARIFF AND REGULATORY ANALYSIS 
           5.8.1 TARIFF FOR CDSS HARDWARE
           5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.8.3 NORTH AMERICA
                    5.8.3.1 Federal Food, Drug, and Cosmetic Act (FD&C Act)
                    5.8.3.2 Health Insurance Portability and Accountability Act (HIPAA)
                    5.8.3.3 Affordable Care Act, 2010
                    5.8.3.4 Health Information Technology for Economic and Clinical Health Act, 2009 (HITECH)
                    5.8.3.5 Consumer Privacy Protection Act, 2017
           5.8.4 EUROPE
                    5.8.4.1 General Data Protection Regulation (GDPR), European Union (EU)
                    5.8.4.2 EU Cybersecurity Act
           5.8.5 ASIA PACIFIC
                    5.8.5.1 China’s Cyber Security Law (CSL)
           5.8.6 REST OF THE WORLD
                    5.8.6.1 Protection of Personal Information Act
                    5.8.6.2 Private cloud computing regulatory framework
    5.9 PORTER'S FIVE FORCES ANALYSIS 
          TABLE 11 CLINICAL DECISION SUPPORT SYSTEM MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF SUPPLIERS
           5.9.4 BARGAINING POWER OF BUYERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 INDUSTRY TRENDS 
           5.10.1 GROWING APPLICATIONS OF AI IN CDSS
           5.10.2 INCREASING FOCUS ON MOBILE & CLOUD-BASED SOLUTIONS
           5.10.3 RISING NEED FOR INTEROPERABILITY & INTEGRATION OF HCIT SOLUTIONS
           5.10.4 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
           5.10.5 INCREASING DEMAND FOR VALUE-BASED HEALTHCARE
    5.11 BUSINESS MODELS 
           FIGURE 30 BENEFITS OF HYBRID BUSINESS MODELS
    5.12 PRICING ANALYSIS 
           5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
                     FIGURE 31 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
                     TABLE 12 AVERAGE SELLING PRICE TREND, BY REGION
    5.13 PATENT ANALYSIS 
           5.13.1 PATENT PUBLICATION TRENDS FOR CLINICAL DECISION SUPPORT SYSTEMS
                     FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
           5.13.2 INSIGHTS INTO JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2011–AUGUST 2023)
           5.13.3 LIST OF PATENTS/PATENT APPLICATIONS FOR CDSS
    5.14 KEY CONFERENCES AND EVENTS 
           TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS: DETAILED LIST OF CONFERENCES AND EVENTS (2023–2024)
    5.15 TRADE ANALYSIS 
           5.15.1 TRADE ANALYSIS FOR CLINICAL DECISION SUPPORT SYSTEM HARDWARE
                     FIGURE 34 IMPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
                     FIGURE 35 EXPORTS OF PRODUCTS UNDER HSN CODE: 901890, BY COUNTRY, 2022 (USD THOUSAND)
    5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                     TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
           5.16.2 BUYING CRITERIA
                     FIGURE 37 CLINICAL DECISION SUPPORT SYSTEMS: KEY BUYING CRITERIA, BY COMPONENT
                     TABLE 15 BUYING CRITERIA FOR COMPONENTS, BY RANK
 
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT (Page No. - 100)
    6.1 INTRODUCTION 
          TABLE 16 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
    6.2 SERVICES 
           6.2.1 RECURRING REQUIREMENT TO DRIVE MARKET
                    TABLE 17 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SOFTWARE 
           6.3.1 USE OF EMR-/EHR-INTEGRATED CDSS TO PROPEL MARKET
                    TABLE 18 CLINICAL DECISION SUPPORT SYSTEM MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 HARDWARE 
           6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH
                    TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT (Page No. - 105)
    7.1 INTRODUCTION 
          TABLE 20 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    7.2 INTEGRATED CDSS 
           7.2.1 INTEGRATION WITH EHRS AND RAPID ACCESS TO PATIENT RECORDS TO DRIVE MARKET
                    TABLE 21 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 STANDALONE CDSS 
           7.3.1 INTEROPERABILITY ISSUES WITH CPOE AND EHR TO RESTRAIN MARKET
                    TABLE 22 STANDALONE CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE (Page No. - 109)
    8.1 INTRODUCTION 
          TABLE 23 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
    8.2 THERAPEUTIC CDSS 
           8.2.1 SEAMLESS INTEGRATION INTO CLINICAL WORKFLOWS TO DRIVE MARKET
                    TABLE 24 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 DIAGNOSTIC CDSS 
           8.3.1 USE OF ALGORITHMS FOR EFFECTIVE REAL-TIME DIAGNOSIS TO SUPPORT MARKET GROWTH
                    TABLE 25 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (Page No. - 113)
    9.1 INTRODUCTION 
          TABLE 26 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
    9.2 KNOWLEDGE-BASED CDSS 
           9.2.1 DEPLOYS CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
                    TABLE 27 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 NON-KNOWLEDGE-BASED CDSS 
           9.3.1 IMPLEMENTS ML AND AI TO EXPAND USER-DEFINED KNOWLEDGE BASE
                    TABLE 28 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE (Page No. - 117)
     10.1 INTRODUCTION 
             TABLE 29 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
     10.2 ON-PREMISE CDSS 
             10.2.1 LOWER RISK OF DATA BREACH AND ABILITY TO CHOOSE MULTIPLE VENDORS TO DRIVE MARKET
                        TABLE 30 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 CLOUD-BASED CDSS 
             10.3.1 FLEXIBLE AND SCALABLE FEATURES TO PROPEL MARKET
                        TABLE 31 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (Page No. - 121)
     11.1 INTRODUCTION 
             TABLE 32 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
     11.2 CONVENTIONAL CDSS 
             11.2.1 ABILITY TO PROVIDE DIAGNOSTIC ASSISTANCE AND PRESCRIPTION DECISION SUPPORT TO DRIVE MARKET
                        TABLE 33 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
     11.3 ADVANCED CDSS 
             11.3.1 REAL-TIME EVIDENCE AND PROTOCOL VALIDATION BENEFITS TO PROPEL MARKET
                        TABLE 34 ADVANCED CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL (Page No. - 125)
     12.1 INTRODUCTION 
             TABLE 35 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
     12.2 ACTIVE CDSS 
             12.2.1 ABILITY TO ENABLE OPTIMAL DECISION-MAKING WITH MINIMAL ERRORS TO DRIVE MARKET
                        TABLE 36 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
     12.3 PASSIVE CDSS 
             12.3.1 MINIMAL DISRUPTION TO WORKFLOWS TO SUPPORT MARKET GROWTH
                        TABLE 37 PASSIVE CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING (Page No. - 129)
     13.1 INTRODUCTION 
             TABLE 38 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
     13.2 INPATIENT SETTINGS 
             13.2.1 GROWING FOCUS ON IMPROVING HEALTHCARE OPERATIONS IN HOSPITALS TO PROPEL MARKET
                        TABLE 39 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
     13.3 AMBULATORY CARE SETTINGS 
             13.3.1 RISING NEED TO CURB HEALTHCARE COSTS TO DRIVE MARKET
                        TABLE 40 CLINICAL DECISION SUPPORT SYSTEM MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
 
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION (Page No. - 133)
     14.1 INTRODUCTION 
             TABLE 41 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2021–2028 (USD MILLION)
     14.2 NORTH AMERICA 
             FIGURE 38 NORTH AMERICA: CDSS MARKET SNAPSHOT
             TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
             TABLE 44 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
             TABLE 45 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 46 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 47 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
             TABLE 48 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
             TABLE 49 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 50 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.2.1 US
                        14.2.1.1 Growing focus on value-based care to drive market
                                      TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 52 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 53 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 54 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 55 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 56 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 57 US: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 58 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.2.2 CANADA
                        14.2.2.1 Rising need to curb healthcare costs to propel market
                                      TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 60 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 61 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 62 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 63 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 64 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 65 CANADA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 66 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.2.3 NORTH AMERICA: RECESSION IMPACT
     14.3 EUROPE 
             TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
             TABLE 69 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
             TABLE 70 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 71 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 72 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
             TABLE 73 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
             TABLE 74 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 75 EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.1 GERMANY
                        14.3.1.1 Favorable government support for adoption of EMRs to propel market
                                      TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 77 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 78 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 79 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 80 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 81 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 82 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 83 GERMANY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.2 UK
                        14.3.2.1 Rising establishment of healthcare facilities to fuel market
                                      TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 85 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 86 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 87 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 88 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 89 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 90 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 91 UK: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.3 FRANCE
                        14.3.3.1 Robust interoperability for EHR systems to drive market
                                      TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 93 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 94 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 95 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 96 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 97 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 98 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 99 FRANCE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.4 ITALY
                        14.3.4.1 Rising need for evidence-based CDSS to drive market
                                      TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 101 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 102 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 103 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 104 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 105 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 106 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 107 ITALY: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.5 SPAIN
                        14.3.5.1 Growing focus on improving patient outcomes to support market growth
                                      TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 109 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 110 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 111 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 112 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 113 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 114 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 115 SPAIN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.6 REST OF EUROPE
                        TABLE 116 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 117 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 118 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 119 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 120 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
                        TABLE 121 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                        TABLE 122 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 123 REST OF EUROPE: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.3.7 EUROPE: RECESSION IMPACT
     14.4 ASIA PACIFIC 
             FIGURE 39 ASIA PACIFIC: CDSS MARKET SNAPSHOT
             TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
             TABLE 126 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
             TABLE 127 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 128 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 129 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
             TABLE 130 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
             TABLE 131 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 132 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.4.1 JAPAN
                        14.4.1.1 Rising need to digitize patient records to propel market
                                      TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 134 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 135 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 136 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 137 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 138 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 139 JAPAN: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 140 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.4.2 CHINA
                        14.4.2.1 Established healthcare reforms for EMR solutions to drive market
                                      TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 142 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 143 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 144 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 145 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 146 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 147 CHINA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 148 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.4.3 INDIA
                        14.4.3.1 Rising adoption of telemedicine to support market growth
                                      TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 150 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 151 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 152 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 153 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 154 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 155 INDIA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 156 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.4.4 REST OF ASIA PACIFIC
                        TABLE 157 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 158 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 159 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 160 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 161 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                        TABLE 162 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                        TABLE 163 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 164 REST OF ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.4.5 ASIA PACIFIC: RECESSION IMPACT
     14.5 REST OF THE WORLD 
             TABLE 165 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 166 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
             TABLE 167 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
             TABLE 168 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 169 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 170 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2021–2028 (USD MILLION)
             TABLE 171 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
             TABLE 172 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 173 REST OF THE WORLD: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.5.1 LATIN AMERICA
                        14.5.1.1 Developments in healthcare infrastructure to support market growth
                                      TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 175 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 176 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 177 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 178 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 179 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 180 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 181 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.5.2 MIDDLE EAST & AFRICA
                        14.5.2.1 Increasing investments in HCIT solutions to propel market
                                      TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 183 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 184 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 185 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 186 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY MODEL, 2021–2028 (USD MILLION)
                                      TABLE 187 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2021–2028 (USD MILLION)
                                      TABLE 188 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEM MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 189 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2021–2028 (USD MILLION)
             14.5.3 REST OF THE WORLD: RECESSION IMPACT
 
15 COMPETITIVE LANDSCAPE (Page No. - 196)
     15.1 OVERVIEW 
     15.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 190 CLINICAL DECISION SUPPORT SYSTEM MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
     15.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS 
             FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS
     15.4 MARKET SHARE ANALYSIS 
             FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
     15.5 COMPANY EVALUATION MATRIX 
             15.5.1 STARS
             15.5.2 EMERGING LEADERS
             15.5.3 PERVASIVE PLAYERS
             15.5.4 PARTICIPANTS
             15.5.5 COMPANY FOOTPRINT
                        TABLE 191 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY FOOTPRINT OF KEY PLAYERS
                        TABLE 192 CLINICAL DECISION SUPPORT SYSTEM MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
                        TABLE 193 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
                        FIGURE 42 CLINICAL DECISION SUPPORT SYSTEM MARKET: COMPANY EVALUATION MATRIX (2022)
     15.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 
             15.6.1 PROGRESSIVE COMPANIES
             15.6.2 RESPONSIVE COMPANIES
             15.6.3 DYNAMIC COMPANIES
             15.6.4 STARTING BLOCKS
                        FIGURE 43 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
                        15.6.4.1 COMPETITIVE BENCHMARKING
                                     TABLE 194 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                                     TABLE 195 CLINICAL DECISION SUPPORT SYSTEM MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
     15.7 COMPETITIVE SITUATIONS AND TRENDS 
             TABLE 196 CLINICAL DECISION SUPPORT SYSTEMS MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (JANUARY 2020–AUGUST 2023)
             15.7.1 DEALS
                        TABLE 197 CLINICAL DECISION SUPPORT SYSTEM MARKET: DEALS (JANUARY 2020–AUGUST 2023)
             15.7.2 OTHER DEVELOPMENTS
                        TABLE 198 CLINICAL DECISION SUPPORT SYSTEMS MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023)
 
16 COMPANY PROFILES (Page No. - 214)
     16.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             16.1.1 EPIC SYSTEMS CORPORATION
                        TABLE 199 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
             16.1.2 WOLTERS KLUWER N.V.
                        TABLE 200 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
                        FIGURE 44 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2022)
             16.1.3 ORACLE
                        TABLE 201 ORACLE: BUSINESS OVERVIEW
                        FIGURE 45 ORACLE: COMPANY SNAPSHOT (2023)
             16.1.4 MERATIVE
                        TABLE 202 MERATIVE: BUSINESS OVERVIEW
             16.1.5 VERADIGM LLC
                        TABLE 203 VERADIGM LLC: BUSINESS OVERVIEW
                        FIGURE 46 VERADIGM LLC: COMPANY SNAPSHOT (2021)
             16.1.6 CHANGE HEALTHCARE (PART OF OPTUM)
                        FIGURE 47 OPTUM.: COMPANY SNAPSHOT (2022)
             16.1.7 ATHENAHEALTH
                        TABLE 205 ATHENA HEALTH: BUSINESS OVERVIEW
             16.1.8 ELSEVIER (DIVISION OF RELX GROUP)
                        TABLE 206 ELSEVIER: BUSINESS OVERVIEW
             16.1.9 ZYNX HEALTH INCORPORATED
                        TABLE 207 ZYNX HEALTH INCORPORATED: BUSINESS OVERVIEW
             16.1.10 KONINKLIJKE PHILIPS N.V.
                        TABLE 208 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 48 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             16.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
                        TABLE 209 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW
             16.1.12 NEXTGEN HEALTHCARE, INC.
                        TABLE 210 NEXTGEN HEALTHCARE, INC.: BUSINESS OVERVIEW
                        FIGURE 49 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)
             16.1.13 CUREMD HEALTHCARE
                        TABLE 211 CUREMD HEALTHCARE: BUSINESS OVERVIEW
             16.1.14 SIEMENS HEALTHINEERS
                        TABLE 212 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
                        FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
             16.1.15 EBSCO INFORMATION SERVICES
                        TABLE 213 EBSCO INFORMATION SERVICES: BUSINESS OVERVIEW
             16.1.16 GE HEALTHCARE
                        TABLE 214 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             16.1.17 ECLINICALWORKS, LLC
                        TABLE 215 ECLINICALWORKS, LLC: BUSINESS OVERVIEW
             16.1.18 THE MEDICAL ALGORITHMS COMPANY LIMITED
                        TABLE 216 THE MEDICAL ALGORITHMS COMPANY LIMITED: BUSINESS OVERVIEW
             16.1.19 HERA-MI
                        TABLE 217 HERA-MI: BUSINESS OVERVIEW
             16.1.20 RAMPMEDICAL
                        TABLE 218 RAMPMEDICAL: BUSINESS OVERVIEW
     16.2 OTHER PLAYERS 
             16.2.1 CARECLOUD, INC.
             16.2.2 VISUALDX
             16.2.3 STANSON HEALTH (PART OF PREMIER, INC.)
             16.2.4 FIRST DATABANK, INC.
             16.2.5 STRATA DECISION TECHNOLOGY
             16.2.6 ALCIDION
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
17 APPENDIX (Page No. - 281)
     17.1 DISCUSSION GUIDE 
     17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     17.3 CUSTOMIZATION OPTIONS 
     17.4 RELATED REPORTS 
     17.5 AUTHOR DETAILS 

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the clinical decision support systems market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Clinical Decision Support Systems  Market Size, and Share

Note 1: C-level primaries include CEOs, CFOs, and COOs.

Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenues. As of 2022 Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Oracle

Product Manager

Change Healthcare

Area Vice President Sales

Merative

Senior Product Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the size of the CDSS market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of CDSS products by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Clinical decision support systems Market Size: Top Down Approach

Clinical Decision Support Systems  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the clinical decision support systems market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable.

Market Definition

Clinical decision support systems are designed to aid in clinical decision-making. These healthcare information technology (HCIT) systems provide timely and person-specific information to healthcare providers to make appropriate clinical decisions based on a patient's circumstances. These platforms ensure healthcare professionals provide evidence-based care to their patients.

Key Stakeholders

  • Senior Management
  • Supply Chain Manager
  • Research & Development Team
  • Product Manager/Sales Manager
  • Hospitals (public and private)
  • Ambulatory surgical centers (ASCs)
  • Surgeons, physicians, and operating room staff

Report Objectives

  • To define, describe, and forecast the global market based on product, component, delivery mode, type, model, application, interactivity level, setting, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa)
  • To strategically analyze the market structure and profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as  acquisitions, product launches & enhancements, expansions, agreements, collaborations, and partnerships in the global CDSS market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 5)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 2237
Published ON
Sep, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Clinical Decision Support Systems Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback